Cargando…
Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASIS
A decade has passed since the publication on the comparison of the effect of adalimumab with data from a historic cohort on the progression of structural damage in the spine of patients with ankylosing spondylitis (AS). No effect could be observed, and currently, there is still no definite proof tha...
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2019
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6836371/ https://www.ncbi.nlm.nih.gov/pubmed/31694713 http://dx.doi.org/10.1186/s13075-019-2045-1 |